Gland Pharma receives Tentative Approval for Cangrelor for Injection

Gland Pharma Limited, a generic injectable focused pharmaceutical company, received a tentative approval from the United States Food and Drug Administration (US FDA) for Cangrelor for Injection, 50 mg/vial Single-Dose Vials.

Gland Pharma believes that we are amongst one of the first to files for this product and may be eligible for 180 days of generic drug exclusivity.

Gland Pharma will launch the product with its marketing partner on receipt of final approval.

Shares of Gland Pharma Limited was last trading in BSE at Rs. 3530.30 as compared to the previous close of Rs. 3548.15. The total number of shares traded during the day was 1731 in over 614 trades.

The stock hit an intraday high of Rs. 3584.05 and intraday low of 3507.00. The net turnover during the day was Rs. 6129328.00.

Source : Equity Bulls

Keywords

GlandPharmaLimited INE068V01023 Pharmaceuticals TentativeApproval Cangrelor USFDA